This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wu WC et al. (2001) Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345: 1230–1236
Hebert PC et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409–417
Nikolsky E et al. (2004) Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Analysis from the CADILLAC trial. J Am Coll Cardiol 44: 547–553
Lee PC et al. (2004) Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44: 541–546
Sharma SK et al. (2000) Cardioprotective effect of prior β-blocker therapy in reducing Creatine Kinase-MB elevation after coronary intervention. Benefit is extended to improvement in intermediate-term survival. Circulation 102: 166–172
Acknowledgements
The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sharma, S. Is mortality raised in patients receiving percutaneous coronary intervention if they suffer from anemia?. Nat Rev Cardiol 1, 74–75 (2004). https://doi.org/10.1038/ncpcardio0042
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0042